Response to the Letter to the Editor: Consideration Needed for Early Anticoagulation Following Intravenous tPA in Patients with COVID-19

J Stroke Cerebrovasc Dis. 2021 Jul;30(7):105789. doi: 10.1016/j.jstrokecerebrovasdis.2021.105789. Epub 2021 Mar 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • COVID-19*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • SARS-CoV-2
  • Tissue Plasminogen Activator / adverse effects

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator